|
|
|
Volumn 64, Issue 4, 1996, Pages 457-458
|
|
Antileprosy drugs, pregnancy and fetal outcome [3]
a
a
a
a
NONE
(India)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOFAZIMINE;
DAPSONE;
PREDNISOLONE;
RIFAMPICIN;
ADOLESCENT;
ADULT;
CLINICAL ARTICLE;
DOSE RESPONSE;
DRUG EFFECT;
DRUG SAFETY;
FEMALE;
HUMAN;
LEPROSY;
LETTER;
PRENATAL DRUG EXPOSURE;
RISK ASSESSMENT;
TERATOGENICITY;
ABNORMALITIES, DRUG-INDUCED;
ADOLESCENT;
ADULT;
ANIMALS;
CLOFAZIMINE;
DAPSONE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INFANT, NEWBORN;
LEPROSTATIC AGENTS;
LEPROSY;
MICE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
RATS;
RETROSPECTIVE STUDIES;
RIFAMPIN;
|
|
EID: 0030477847
PISSN: 0148916X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (8)
|
|
References (8)
|
